W6/32 is a mouse monoclonal antibody that specifically recognizes a monomorphic epitope on human HLA class I molecules (i.e., HLAA, HLAB, HLAC), and is widely used in human immunology for detection of these antigens. In in vivo mouse studies, its direct use is very limited due to species specificity; the W6/32 antibody reacts weakly or not at all with native mouse MHC class I molecules unless specific experimental manipulations are performed.

Key context and limitations in mouse studies:

• Species restriction: W6/32 does not recognize native murine MHC class I molecules under normal physiological conditions because its conformational epitope is dependent on both the MHC class I heavy chain and the species origin of β2microglobulin.
• Experimental crossreactivity: W6/32 can bind to mouse MHC class I (particularly some alleles like H2Db or H2Kd), but only if the mouse class I heavy chain is associated with human or bovine β2microglobulin instead of mouse β2microglobulin. This can sometimes be achieved:
  • In vitro by culturing mouse cells with human or bovine β2microglobulin supplementation.
  • In vivo by injection of human or bovine β2microglobulin into mice, which leads to the formation of H2 (mouse class I)—human/bovine β2microglobulin complexes that are recognized by W6/32.

Applications and practical caveats in mouse models:

• Direct detection of endogenous mouse class I: Not routinely feasible, as W6/32 does not robustly detect murine class I antigen under normal conditions.
• Detection of humanized or chimeric molecules: In transgenic or humanized mice expressing human HLA class I proteins, W6/32 can be used for detection and manipulation (e.g., depletion, imaging, tissue staining).
• Special experimental use: For rare studies probing mouse–human class I chimeras or investigating β2microglobulin exchange, W6/32 may serve as a probe to study heterologous MHC class I/β2m alignments.

Summary Table: W6/32 Use in Mice

In summary, W6/32 is not used for general MHC class I detection in wildtype mice. It can only be used to detect HLA class I in genetically modified or xenografted mice, or in murine cells experimentally complexed with human or bovine β2microglobulin.

Commonly used antibodies or proteins often paired with W6/32 in the literature include:

• β2microglobulin (β2m): W6/32 recognizes properly folded HLA class I molecules, which requires noncovalent association with β2microglobulin; many studies specifically examine this interaction or use antiβ2m antibodies alongside W6/32 to confirm formation of mature HLA class I complexes.
• Allelespecific HLA monoclonal antibodies: These include antibodies targeting particular HLAA, HLAB, or HLAC alleles (e.g., BB7.2 for HLAA2). Such antibodies are used to dissect allelespecific surface expression versus panclass I detected by W6/32.
• Antibodies against HLA class II (e.g., L243, antiHLADR): Often used as counterstains or comparative markers to distinguish class I versus class II molecules on cells within flow cytometry or immunoassays.
• Antibodies to lineage or cell markers: W6/32 is used in conjunction with markers such as CD3 (T cells), CD19 (B cells), or CD45 (leukocytes) for multiparametric cell characterization in flow cytometry and immunophenotyping.
• Isotypematched negative controls: Mouse IgG2a isotype controls are routinely used alongside W6/32 to ensure signal specificity, since W6/32 is also an IgG2a subclass.
• Soluble or recombinant MHC/peptide complexes: For structural and biochemical studies, W6/32 is employed with peptideloaded soluble HLA class I molecules and recombinant β2microglobulin to assess correct conformation and binding.
• Other panHLA class I antibodies: Examples include clones such as HC10, which recognizes free HLAB and C heavy chains not associated with β2m, and are used to probe different conformational or assembly states of class I MHC proteins.

In sum, W6/32 is commonly combined with antiβ2microglobulin, allelespecific antiHLA antibodies, class II antibodies, lineage markers, isotype controls, and other conformational antibodies to HLA class I to dissect surface expression, molecular assembly, or cell subset specificity in immunology and transplantation literature.

The monoclonal antibody W6/32 is a key reagent in immunology, widely cited for its role in detecting human HLA class I molecules (HLAA, HLAB, HLAC). Key findings from its use in scientific literature include:

• Recognition of a Conserved Epitope on HLA Class I:
  W6/32 binds a conformational determinant on the alpha2 and alpha3 domains of HLAA, B, and C heavy chains, specifically recognizing a surface structure requiring association with β2microglobulin for proper folding and stability.

• Standard Reagent for Purification and Quantitation of HLA I:
  The antibody is routinely used for the immunoaffinity purification of native HLA class I molecules from cells or tissues, often as the standard tool to measure and isolate HLAA, B, and C across different cell types and preparations.

• Functional Role in Peptidome and Structural Studies:
  W6/32 enables highconfidence purification and analysis of HLApeptide complexes, essential for mass spectrometric profiling of the HLA peptidome. It reliably isolates HLA class I molecules for structural and peptide repertoire studies, including research on antigen processing and tapasin dependence.

• Cell Surface Quantification:
  W6/32 binding has been used to quantify HLA class I copy number per cell, showing that B cell lines express significantly more HLAA, B, and C on the surface than peripheral blood lymphocytes.

• Stability Dependent on β2Microglobulin:
  W6/32’s binding is enhanced or dependent on the presence of β2microglobulin—its recognized epitope requires the heavy chain to be nondenatured and complexed with β2m.

• Validation Across Multiple Species and Applications:
  Although highly specific for human HLA, W6/32 partially crossreacts with MHC class I from other primates. It's routinely validated for flow cytometry, immunohistochemistry, and immunofluorescence due to its high specificity and reproducibility.

• Trusted and Highly Cited:
  The antibody is extensively cited—over 36 times in peerreviewed journals for just one commercial product—and recognized as a gold standard for studying HLA class I expression and function.

In summary, W6/32’s primary scientific importance lies in enabling highly sensitive, specific, and reproducible detection, quantification, and purification of native HLA class I molecules, underpinning foundational studies in immunogenetics and antigen presentation.

Dosing regimens for clone W6/32 (antihuman HLA class I) in mouse models are not standardized due to its primary use in flow cytometry and immunofluorescence rather than in vivo functional assays. Published product specifications and usage citations commonly report the antibody is used for ex vivo staining of human cells, not for dosing live mice.

Key points:

• W6/32 is a mouse monoclonal IgG2a antibody directed against human HLAA, B, and C (class I MHC).
• It is routinely used for flow cytometry, immunohistochemistry (frozen sections), and immunocytochemistry—typically as a reagent for labeling cells in vitro.

In vivo dosing in mice:

• There is limited evidence in primary literature or antibody supplier protocols that W6/32 is administered as a dosing regimen in live mice, unlike immunemodulating antibodies such as antiCTLA4 or antiCD3.
• One report indicates that W6/32 binding to mouse cells is only revealed when human or bovine beta2microglobulin is present, and is temperaturedependent, suggesting mouse models do not naturally present the target epitope unless human components are engineered in.

If used in mouse models:

• It would likely be within humanized or chimeric mouse strains engineered to express human HLA class I molecules.
• No typical dosing amounts, schedules, or routes (such as intraperitoneal or intravenous injection) are established for clone W6/32 in the context of mouse in vivo studies.
• Published antibody concentrations for in vitro assays (e.g., flow cytometry) range from 0.1–2 µg per test or per million cells, but these should not be directly extrapolated to systemic mouse dosing.

Comparison to other monoclonal antibodies used in mice:

Summary:
Clone W6/32 is not routinely administered as a systemic dose in mouse models and thus does not have established dosing regimens across mouse strains. Its use is primarily restricted to ex vivo/in vitro detection of human HLA class I molecules. If used in humanized mouse models, dosing would be determined by experimental goals, but no consensus regimen is documented in public or supplier sources.